Optimizing outcomes and personalizing care with targeted agents in advanced cholangiocarcinoma
Cancer Treatment Reviews · 2024
DOI: 10.1016/j.ctrv.2024.102851 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2024. Verfasst von Umair Mahmood und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Oncology, University College Hospital NHS Foundation Trust (UCLH), London NW1 2BU, UK. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Molecular Targeted Therapy, Precision Medicine, Bile Duct Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 87 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Oncology, University College Hospital NHS Foundation Trust (UCLH), London NW1 2BU, UK.
- Department of Gastrointestinal Oncology, University College Hospital NHS Foundation Trust (UCLH), London NW1 2BU, UK; University College London Cancer Institute, London WC1E 6DD, UK. Electronic address: khurum.khan1@nhs…
Zitieren
APA
Mahmood, U., Abbass, A., & Khan, K. (2024). Optimizing outcomes and personalizing care with targeted agents in advanced cholangiocarcinoma. Cancer Treatment Reviews. https://doi.org/10.1016/j.ctrv.2024.102851
Vancouver
Mahmood U, Abbass A, Khan K. Optimizing outcomes and personalizing care with targeted agents in advanced cholangiocarcinoma. Cancer Treatment Reviews. 2024. doi:10.1016/j.ctrv.2024.102851
BibTeX
@article{Mahmood2024,
author = {Mahmood, Umair and Abbass, Ahmed and Khan, Khurum},
title = {Optimizing outcomes and personalizing care with targeted agents in advanced cholangiocarcinoma},
journal = {Cancer Treatment Reviews},
year = {2024},
doi = {10.1016/j.ctrv.2024.102851}
}
EUVIMED